Cannabis and Nausea
Cannabinoids reduce chemotherapy nausea; evidence is weak for other causes.
This article is for information only and is not medical advice. Talk to a doctor before using cannabis for a health condition, and do not stop or change prescribed treatment on your own.
THC is FDA-approved for chemotherapy nausea and has solid evidence for that narrow use. Outside cancer, the evidence falls off a cliff. Heavy users can develop the opposite problem—cannabinoid hyperemesis syndrome, a paradoxical vomiting disorder. Most medical cannabis patients report nausea relief, but those reports are uncontrolled and reflect expectancy. For everyday nausea, ondansetron works better and is safer.
Not Medical Advice
This article is not medical advice. It summarizes published evidence for educational purposes only. Nausea can signal serious conditions including bowel obstruction, infection, pregnancy complications, or neurological disease. If you experience nausea lasting more than a few days, vomit blood, cannot retain fluids, are pregnant, or are undergoing cancer treatment, consult a clinician before using cannabis or other self-treatments. Cannabis interacts with many medications and remains illegal in many jurisdictions.
Plain-Language Summary
Nausea is the sensation of imminent vomiting; vomiting is the act itself. Both are coordinated by networks in the brainstem (the area postrema and nucleus tractus solitarius) and the gut, responding to drugs that target serotonin, dopamine, histamine, and the endocannabinoid system.
THC, cannabis's main intoxicating compound, activates CB1 receptors in those brainstem regions. Strong evidence [1][2] This is why two isolated THC drugs—dronabinol and nabilone—have been FDA-approved since the 1980s for chemotherapy-induced nausea and vomiting (CINV) that doesn't respond to standard drugs. [3]
Whole-plant cannabis (smoked, vaporized, or eaten) is less rigorously studied than isolated drugs, but observational and some randomized data suggest it also helps CINV. Strong evidence [2][4] Outside chemotherapy, the evidence weakens substantially, and for many common causes of nausea (pregnancy, motion sickness, hangover), controlled data are absent or do not support use.
What Probably Works
Chemotherapy-Induced Nausea and Vomiting (CINV)
This is the single best-supported use of cannabinoids for nausea. A 2015 JAMA systematic review found moderate-quality evidence supporting cannabinoids (predominantly dronabinol and nabilone) over placebo for CINV. Strong evidence [1] The 2017 National Academies report on cannabis and health concluded there is "conclusive evidence" that oral cannabinoids are effective for CINV. Strong evidence [2] A Cochrane review of cannabis-based medicines for CINV in adults also documented benefit, though it noted that side effects (dizziness, dysphoria, sedation) often limit tolerability. Strong evidence [4]
Mechanism
CB1 receptors in the dorsal vagal complex suppress the emetic reflex. [5] CBD also reduces nausea in animal models at low doses, partly through indirect activation of 5-HT1A serotonin receptors, though human evidence is sparse. Weak / limited [5]
Practical Role in Treatment
Modern 5-HT3 antagonists (ondansetron, granisetron) combined with NK1 antagonists (aprepitant) and dexamethasone are first-line for CINV and are highly effective. [3] Cannabinoids are typically reserved for breakthrough nausea, when standard regimens fail, or as adjuncts—not as initial treatment. [3]
What Might Work
HIV/AIDS-Associated Nausea and Wasting
Dronabinol was originally approved for AIDS-related appetite loss, and fair evidence shows it improves appetite and reduces associated nausea. Weak / limited [2] Modern HIV therapy has transformed disease prognosis and symptom burden; this indication is now rarely used.
Postoperative Nausea and Vomiting (PONV)
Small trials of nabilone and dronabinol for PONV show mixed results—some demonstrating benefit, others showing no effect or worsening nausea. Weak / limited [6] Not recommended for standard perioperative care.
Functional Dyspepsia, Gastroparesis, and Cyclic Vomiting Syndrome
Patients often report relief from cannabis for these conditions. Anecdote Controlled trials are minimal to absent. A relevant concern: cannabis itself can trigger cyclic vomiting in heavy daily users (see "Risks" below), warranting caution in patients with a history of cyclic symptoms.
General or Unspecified Nausea
Many medical cannabis patients list nausea as a symptom and report symptom reduction. Weak / limited [7] These are uncontrolled observational reports and are subject to expectancy bias—the placebo effect is especially strong for subjective symptoms like nausea.
What Doesn't Work (Or Lacks Evidence)
Morning Sickness and Pregnancy-Related Nausea
No randomized trials support cannabis for pregnancy nausea. No data Despite anecdotal use, major obstetric organizations including the American College of Obstetricians and Gynecologists recommend against cannabis in pregnancy because prenatal exposure is associated with lower birth weight and neurodevelopmental concerns. Strong evidence [8] Whatever symptom relief patients report has not been weighed against fetal risk in any controlled study. See Cannabis and Pregnancy Nausea for details.
Motion Sickness
No quality evidence exists. Anecdotal reports are mixed—some users report relief, others report increased nausea. No data
Hangover Nausea
No controlled data. No data
CBD Alone for Nausea
Despite preclinical promise, human randomized trials of isolated CBD as an antiemetic are essentially absent. No data Marketing claims that "CBD oil treats nausea" lack clinical support.
What We Don't Know
- The optimal dose, route (inhaled vs. oral), and chemotype (THC:CBD ratio, terpene profile) of whole-plant cannabis for nausea. Most trial data come from oral THC drugs, not inhaled flower.
- Whether specific terpenes (limonene, caryophyllene, pinene) contribute meaningfully to antiemetic effects in humans. This claim appears widely in marketing but is not demonstrated in controlled studies. Anecdote
- Whether CBD or balanced CBD:THC combinations outperform THC alone for nausea.
- Long-term comparative effectiveness and safety vs. modern antiemetics.
- Why some chronic daily cannabis users develop Cannabis and Gastroparesis (cannabinoid hyperemesis syndrome) and others do not, or what dose or duration of use confers risk.
Comparison With Standard Treatments
For CINV, the modern evidence-based standard combines:
- 5-HT3 antagonists (ondansetron, granisetron, palonosetron)—first-line, well-tolerated, highly effective.
- NK1 antagonists (aprepitant)—added for highly emetogenic chemotherapy regimens.
- Corticosteroids (dexamethasone)—used in combination protocols.
- Olanzapine—increasingly used as a second-line or breakthrough agent; strong evidence in refractory nausea.
Historical trials from the 1980s and 1990s showed oral THC and nabilone outperforming older antiemetics like prochlorperazine, but those comparisons predate the 5-HT3 era and are now outdated for clinical decision-making. [1][3] Cannabinoids today are positioned as second- or third-line agents or as adjuncts for breakthrough symptoms, not as replacements for ondansetron-based regimens. [3]
For non-chemotherapy nausea (functional dyspepsia, postoperative nausea, motion sickness, gastroenteritis), standard antiemetics (ondansetron, metoclopramide, promethazine, antihistamines, or ginger) have stronger or comparable evidence than cannabis and are the preferred first-line options.
Risks and Side Effects
Cannabinoid Hyperemesis Syndrome (CHS)
Chronic heavy cannabis users (typically daily, high-dose) can develop a paradoxical syndrome of severe, recurrent vomiting, often temporarily relieved by hot showers or baths. Strong evidence [9] The syndrome resolves only with sustained cannabis cessation. [9] If you use cannabis daily and develop new cycles of intractable vomiting, suspect CHS and consult a clinician.
Acute Side Effects of THC
Common in CINV trials: dizziness, dysphoria, anxiety, sedation, tachycardia, and impaired cognition. [1][4] These effects are significant enough that some patients discontinue the drug.
Pregnancy
Avoid cannabis in pregnancy. Prenatal exposure is linked to lower birth weight and neurodevelopmental effects. [8]
Drug Interactions
THC and CBD are metabolized by CYP3A4 and CYP2C9/2C19. CBD inhibits several CYP enzymes and can elevate levels of other drugs (e.g., clobazam, warfarin, certain statins). Strong evidence [10] If you take prescription medications, discuss cannabis use with your pharmacist or doctor before use. See Cannabis and Polypharmacy Risks.
Tolerance and Dependence
Regular use leads to tolerance to antiemetic effects. Heavy daily use is associated with cannabis use disorder in approximately 1 in 10 overall users, with higher rates among daily users.
Smoking and Respiratory Risk
In cancer or chemotherapy patients, smoked cannabis carries pulmonary risks. Oral or vaporized forms are usually preferred for this population.
Sources
- Peer-reviewed Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA. 2015;313(24):2456–2473.
- Government National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press; 2017.
- Government National Cancer Institute. Cannabis and Cannabinoids (PDQ®)–Health Professional Version. Updated 2024.
- Peer-reviewed Smith LA, Azariah F, Lavender VT, Stoner NS, Bettiol S. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Cochrane Database of Systematic Reviews. 2015;(11):CD009464.
- Peer-reviewed Parker LA, Rock EM, Limebeer CL. Regulation of nausea and vomiting by cannabinoids. British Journal of Pharmacology. 2011;163(7):1411–1422.
- Peer-reviewed Levin DN, Dulberg Z, Chan AW, Hare GM, Mazer CD, Hong A. A randomized-controlled trial of nabilone for the prevention of acute postoperative nausea and vomiting in elective surgery. Canadian Journal of Anesthesia. 2017;64(4):385–395.
- Peer-reviewed Stith SS, Li X, Orozco J, et al. The Effectiveness of Common Cannabis Products for Treatment of Nausea. Journal of Clinical Gastroenterology. 2022;56(4):331–338.
- Government American College of Obstetricians and Gynecologists. Committee Opinion No. 722: Marijuana Use During Pregnancy and Lactation. Obstetrics & Gynecology. 2017;130(4):e205–e209. Reaffirmed 2021.
- Peer-reviewed Sorensen CJ, DeSanto K, Borgelt L, Phillips KT, Monte AA. Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment—a Systematic Review. Journal of Medical Toxicology. 2017;13(1):71–87.
- Peer-reviewed Brown JD, Winterstein AG. Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use. Journal of Clinical Medicine. 2019;8(7):989.
How this page was made
Generation history
Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.
Related
- Cannabis and Chemotherapy-Induced Nausea and Vomiting — Synthetic THC drugs treat refractory CINV, but modern antiemetics remain first-line. Smoke...
- Cannabis and Gastroparesis — Cannabis reduces nausea but worsens gastric emptying. No proven benefit; risks include can...
- Cannabis in Palliative Care — Evidence and risks of cannabis and cannabinoid medicines in serious illness and end-of-lif...
- Cannabis and Polypharmacy Risks — How cannabis affects multiple-medication regimens, and which interactions are real.
- Cannabis and Pregnancy Nausea — Nausea relief reported by pregnant users, but substantial fetal risks and no controlled tr...